Tech talk references: 21 August 2006
Presenter: Travis
Complex target selections
- Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, and Tan W. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11838-43. DOI:10.1073/pnas.0602615103 | PubMed ID:16873550 | HubMed [tech1]
- Morris KN, Jensen KB, Julin CM, Weil M, and Gold L. High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2902-7. DOI:10.1073/pnas.95.6.2902 | PubMed ID:9501188 | HubMed [tech2]
- Daniels DA, Chen H, Hicke BJ, Swiderek KM, and Gold L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15416-21. DOI:10.1073/pnas.2136683100 | PubMed ID:14676325 | HubMed [tech3]
All Medline abstracts: PubMed | HubMed
Aptamer drug/siRNA/qdot conjugates
<biblio>
- tech4 pmid=16778167
- tech5 pmid=16740739
- tech6 pmid=16823371
- tech7 pmid=16495043
- tech8 pmid=15520166
|